nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0871	0.0977	CbGbCtD
Lovastatin—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0781	0.0876	CbGbCtD
Lovastatin—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0765	0.0858	CbGbCtD
Lovastatin—SLCO1A2—Prednisone—ankylosing spondylitis	0.0738	0.0827	CbGbCtD
Lovastatin—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.046	0.0517	CbGbCtD
Lovastatin—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0383	0.043	CbGbCtD
Lovastatin—ABCC2—Dexamethasone—ankylosing spondylitis	0.0382	0.0428	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—ankylosing spondylitis	0.037	0.0415	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0349	0.0392	CbGbCtD
Lovastatin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0329	0.0369	CbGbCtD
Lovastatin—ABCC2—Methotrexate—ankylosing spondylitis	0.0307	0.0344	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0255	0.0286	CbGbCtD
Lovastatin—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0255	0.0286	CbGbCtD
Lovastatin—CYP2C19—Prednisone—ankylosing spondylitis	0.0247	0.0277	CbGbCtD
Lovastatin—ABCB1—Betamethasone—ankylosing spondylitis	0.0214	0.024	CbGbCtD
Lovastatin—ABCB1—Prednisolone—ankylosing spondylitis	0.0211	0.0237	CbGbCtD
Lovastatin—ABCB1—Prednisone—ankylosing spondylitis	0.0199	0.0224	CbGbCtD
Lovastatin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0197	0.0221	CbGbCtD
Lovastatin—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0191	0.0215	CbGbCtD
Lovastatin—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0184	0.0206	CbGbCtD
Lovastatin—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0154	0.0173	CbGbCtD
Lovastatin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0149	0.0168	CbGbCtD
Lovastatin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0128	0.0144	CbGbCtD
Lovastatin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0128	0.0144	CbGbCtD
Lovastatin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0126	0.0142	CbGbCtD
Lovastatin—ABCB1—Dexamethasone—ankylosing spondylitis	0.0124	0.014	CbGbCtD
Lovastatin—CYP3A4—Prednisone—ankylosing spondylitis	0.0119	0.0134	CbGbCtD
Lovastatin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0117	0.0132	CbGbCtD
Lovastatin—ABCB1—Methotrexate—ankylosing spondylitis	0.01	0.0112	CbGbCtD
Lovastatin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00746	0.00836	CbGbCtD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—KIR3DL1—ankylosing spondylitis	0.00096	0.232	CbGpPWpGaD
Lovastatin—Vasculitis—Methotrexate—ankylosing spondylitis	0.000518	0.00496	CcSEcCtD
Lovastatin—Pancreatitis—Prednisolone—ankylosing spondylitis	0.000512	0.0049	CcSEcCtD
Lovastatin—Vascular purpura—Prednisone—ankylosing spondylitis	0.000491	0.0047	CcSEcCtD
Lovastatin—Influenza—Triamcinolone—ankylosing spondylitis	0.00048	0.0046	CcSEcCtD
Lovastatin—Injury—Prednisone—ankylosing spondylitis	0.000478	0.00457	CcSEcCtD
Lovastatin—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.000471	0.00451	CcSEcCtD
Lovastatin—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00047	0.0045	CcSEcCtD
Lovastatin—Amnesia—Prednisone—ankylosing spondylitis	0.000468	0.00448	CcSEcCtD
Lovastatin—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000457	0.00437	CcSEcCtD
Lovastatin—Purpura—Prednisone—ankylosing spondylitis	0.000456	0.00436	CcSEcCtD
Lovastatin—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.000452	0.00433	CcSEcCtD
Lovastatin—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00042	0.00402	CcSEcCtD
Lovastatin—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000419	0.00401	CcSEcCtD
Lovastatin—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000418	0.004	CcSEcCtD
Lovastatin—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000408	0.00391	CcSEcCtD
Lovastatin—ITGAL—Beta2 integrin cell surface interactions—CD40LG—ankylosing spondylitis	0.000399	0.0962	CbGpPWpGaD
Lovastatin—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000381	0.00365	CcSEcCtD
Lovastatin—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000381	0.00365	CcSEcCtD
Lovastatin—Pancreatitis—Prednisone—ankylosing spondylitis	0.000372	0.00356	CcSEcCtD
Lovastatin—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00035	0.00335	CcSEcCtD
Lovastatin—Vision blurred—Prednisolone—ankylosing spondylitis	0.000343	0.00328	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000338	0.00323	CcSEcCtD
Lovastatin—Angioedema—Prednisolone—ankylosing spondylitis	0.000333	0.00318	CcSEcCtD
Lovastatin—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000332	0.00318	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000331	0.00316	CcSEcCtD
Lovastatin—Malaise—Prednisolone—ankylosing spondylitis	0.000328	0.00314	CcSEcCtD
Lovastatin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000328	0.00314	CcSEcCtD
Lovastatin—Vertigo—Prednisolone—ankylosing spondylitis	0.000327	0.00313	CcSEcCtD
Lovastatin—Back pain—Triamcinolone—ankylosing spondylitis	0.000324	0.0031	CcSEcCtD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-C—ankylosing spondylitis	0.000317	0.0765	CbGpPWpGaD
Lovastatin—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000314	0.00301	CcSEcCtD
Lovastatin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000311	0.00298	CcSEcCtD
Lovastatin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000311	0.00297	CcSEcCtD
Lovastatin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00031	0.00297	CcSEcCtD
Lovastatin—Alopecia—Betamethasone—ankylosing spondylitis	0.000308	0.00295	CcSEcCtD
Lovastatin—Alopecia—Dexamethasone—ankylosing spondylitis	0.000308	0.00295	CcSEcCtD
Lovastatin—Discomfort—Prednisolone—ankylosing spondylitis	0.000306	0.00293	CcSEcCtD
Lovastatin—Angioedema—Triamcinolone—ankylosing spondylitis	0.000306	0.00293	CcSEcCtD
Lovastatin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000305	0.00292	CcSEcCtD
Lovastatin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000304	0.00291	CcSEcCtD
Lovastatin—Malaise—Triamcinolone—ankylosing spondylitis	0.000302	0.00289	CcSEcCtD
Lovastatin—Malaise—Methylprednisolone—ankylosing spondylitis	0.000301	0.00288	CcSEcCtD
Lovastatin—Vertigo—Triamcinolone—ankylosing spondylitis	0.000301	0.00288	CcSEcCtD
Lovastatin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.0003	0.00287	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000297	0.00284	CcSEcCtD
Lovastatin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000292	0.0028	CcSEcCtD
Lovastatin—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00029	0.00277	CcSEcCtD
Lovastatin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000285	0.00273	CcSEcCtD
Lovastatin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000284	0.00272	CcSEcCtD
Lovastatin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000284	0.00272	CcSEcCtD
Lovastatin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000283	0.00271	CcSEcCtD
Lovastatin—Flushing—Prednisone—ankylosing spondylitis	0.000282	0.0027	CcSEcCtD
Lovastatin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000282	0.0027	CcSEcCtD
Lovastatin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000282	0.0027	CcSEcCtD
Lovastatin—Discomfort—Triamcinolone—ankylosing spondylitis	0.000282	0.0027	CcSEcCtD
Lovastatin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000281	0.00269	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00028	0.00269	CcSEcCtD
Lovastatin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000279	0.00267	CcSEcCtD
Lovastatin—Angioedema—Dexamethasone—ankylosing spondylitis	0.000278	0.00266	CcSEcCtD
Lovastatin—Angioedema—Betamethasone—ankylosing spondylitis	0.000278	0.00266	CcSEcCtD
Lovastatin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000275	0.00263	CcSEcCtD
Lovastatin—Malaise—Betamethasone—ankylosing spondylitis	0.000274	0.00262	CcSEcCtD
Lovastatin—Malaise—Dexamethasone—ankylosing spondylitis	0.000274	0.00262	CcSEcCtD
Lovastatin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000273	0.00262	CcSEcCtD
Lovastatin—Vertigo—Betamethasone—ankylosing spondylitis	0.000273	0.00261	CcSEcCtD
Lovastatin—Vertigo—Dexamethasone—ankylosing spondylitis	0.000273	0.00261	CcSEcCtD
Lovastatin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000273	0.00261	CcSEcCtD
Lovastatin—Infection—Triamcinolone—ankylosing spondylitis	0.000271	0.0026	CcSEcCtD
Lovastatin—Infection—Methylprednisolone—ankylosing spondylitis	0.000271	0.00259	CcSEcCtD
Lovastatin—Insomnia—Prednisolone—ankylosing spondylitis	0.000269	0.00257	CcSEcCtD
Lovastatin—Alopecia—Prednisone—ankylosing spondylitis	0.000269	0.00257	CcSEcCtD
Lovastatin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000267	0.00255	CcSEcCtD
Lovastatin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000259	0.00248	CcSEcCtD
Lovastatin—Myalgia—Betamethasone—ankylosing spondylitis	0.000259	0.00248	CcSEcCtD
Lovastatin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000258	0.00247	CcSEcCtD
Lovastatin—Anxiety—Betamethasone—ankylosing spondylitis	0.000258	0.00247	CcSEcCtD
Lovastatin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000255	0.00245	CcSEcCtD
Lovastatin—Discomfort—Betamethasone—ankylosing spondylitis	0.000255	0.00245	CcSEcCtD
Lovastatin—Pain—Prednisolone—ankylosing spondylitis	0.000254	0.00243	CcSEcCtD
Lovastatin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000254	0.00243	CcSEcCtD
Lovastatin—Vision blurred—Prednisone—ankylosing spondylitis	0.000249	0.00239	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000249	0.00238	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000248	0.00238	CcSEcCtD
Lovastatin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000248	0.00237	CcSEcCtD
Lovastatin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000248	0.00237	CcSEcCtD
Lovastatin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000247	0.00237	CcSEcCtD
Lovastatin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000247	0.00236	CcSEcCtD
Lovastatin—Infection—Betamethasone—ankylosing spondylitis	0.000246	0.00236	CcSEcCtD
Lovastatin—Infection—Dexamethasone—ankylosing spondylitis	0.000246	0.00236	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000245	0.00235	CcSEcCtD
Lovastatin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000245	0.00235	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000245	0.00234	CcSEcCtD
Lovastatin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000245	0.00234	CcSEcCtD
Lovastatin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000244	0.00233	CcSEcCtD
Lovastatin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000243	0.00232	CcSEcCtD
Lovastatin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000243	0.00232	CcSEcCtD
Lovastatin—Angioedema—Prednisone—ankylosing spondylitis	0.000242	0.00231	CcSEcCtD
Lovastatin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00024	0.0023	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00024	0.0023	CcSEcCtD
Lovastatin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00024	0.0023	CcSEcCtD
Lovastatin—Malaise—Prednisone—ankylosing spondylitis	0.000239	0.00228	CcSEcCtD
Lovastatin—Vertigo—Prednisone—ankylosing spondylitis	0.000238	0.00228	CcSEcCtD
Lovastatin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000236	0.00226	CcSEcCtD
Lovastatin—Anorexia—Betamethasone—ankylosing spondylitis	0.000236	0.00226	CcSEcCtD
Lovastatin—Urticaria—Prednisolone—ankylosing spondylitis	0.000236	0.00226	CcSEcCtD
Lovastatin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000236	0.00226	CcSEcCtD
Lovastatin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000235	0.00225	CcSEcCtD
Lovastatin—Pain—Triamcinolone—ankylosing spondylitis	0.000234	0.00224	CcSEcCtD
Lovastatin—Chills—Methotrexate—ankylosing spondylitis	0.000228	0.00218	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000226	0.00216	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000226	0.00216	CcSEcCtD
Lovastatin—Arthralgia—Prednisone—ankylosing spondylitis	0.000225	0.00216	CcSEcCtD
Lovastatin—Myalgia—Prednisone—ankylosing spondylitis	0.000225	0.00216	CcSEcCtD
Lovastatin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000225	0.00216	CcSEcCtD
Lovastatin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000225	0.00215	CcSEcCtD
Lovastatin—Anxiety—Prednisone—ankylosing spondylitis	0.000224	0.00215	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—ankylosing spondylitis	0.000224	0.00215	CcSEcCtD
Lovastatin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000224	0.00215	CcSEcCtD
Lovastatin—Insomnia—Betamethasone—ankylosing spondylitis	0.000224	0.00215	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000223	0.00213	CcSEcCtD
Lovastatin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000223	0.00213	CcSEcCtD
Lovastatin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000223	0.00213	CcSEcCtD
Lovastatin—Discomfort—Prednisone—ankylosing spondylitis	0.000223	0.00213	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000219	0.0021	CcSEcCtD
Lovastatin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000218	0.00209	CcSEcCtD
Lovastatin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000218	0.00209	CcSEcCtD
Lovastatin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000217	0.00208	CcSEcCtD
Lovastatin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000217	0.00207	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000216	0.00207	CcSEcCtD
Lovastatin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000216	0.00207	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000216	0.00207	CcSEcCtD
Lovastatin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000215	0.00206	CcSEcCtD
Lovastatin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000215	0.00206	CcSEcCtD
Lovastatin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000215	0.00206	CcSEcCtD
Lovastatin—Infection—Prednisone—ankylosing spondylitis	0.000214	0.00205	CcSEcCtD
Lovastatin—Back pain—Methotrexate—ankylosing spondylitis	0.000214	0.00205	CcSEcCtD
Lovastatin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000214	0.00205	CcSEcCtD
Lovastatin—Fatigue—Betamethasone—ankylosing spondylitis	0.000214	0.00205	CcSEcCtD
Lovastatin—Pain—Betamethasone—ankylosing spondylitis	0.000212	0.00203	CcSEcCtD
Lovastatin—Pain—Dexamethasone—ankylosing spondylitis	0.000212	0.00203	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000208	0.00199	CcSEcCtD
Lovastatin—Anorexia—Prednisone—ankylosing spondylitis	0.000206	0.00197	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000205	0.00196	CcSEcCtD
Lovastatin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000204	0.00196	CcSEcCtD
Lovastatin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000204	0.00196	CcSEcCtD
Lovastatin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000203	0.00194	CcSEcCtD
Lovastatin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000203	0.00194	CcSEcCtD
Lovastatin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000201	0.00193	CcSEcCtD
Lovastatin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000201	0.00192	CcSEcCtD
Lovastatin—Malaise—Methotrexate—ankylosing spondylitis	0.000199	0.00191	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—ankylosing spondylitis	0.000199	0.0019	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000198	0.00189	CcSEcCtD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—CD40LG—ankylosing spondylitis	0.000197	0.0476	CbGpPWpGaD
Lovastatin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000197	0.00189	CcSEcCtD
Lovastatin—Urticaria—Betamethasone—ankylosing spondylitis	0.000197	0.00189	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000197	0.00188	CcSEcCtD
Lovastatin—Dizziness—Prednisolone—ankylosing spondylitis	0.000196	0.00188	CcSEcCtD
Lovastatin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000196	0.00188	CcSEcCtD
Lovastatin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000196	0.00188	CcSEcCtD
Lovastatin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000196	0.00188	CcSEcCtD
Lovastatin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000196	0.00188	CcSEcCtD
Lovastatin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000196	0.00188	CcSEcCtD
Lovastatin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000196	0.00187	CcSEcCtD
Lovastatin—Insomnia—Prednisone—ankylosing spondylitis	0.000195	0.00187	CcSEcCtD
Lovastatin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000194	0.00186	CcSEcCtD
Lovastatin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000193	0.00185	CcSEcCtD
Lovastatin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000193	0.00185	CcSEcCtD
Lovastatin—Dyspepsia—Prednisone—ankylosing spondylitis	0.00019	0.00182	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—ankylosing spondylitis	0.000188	0.0018	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000188	0.0018	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—ankylosing spondylitis	0.000188	0.0018	CcSEcCtD
Lovastatin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000188	0.0018	CcSEcCtD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-B—ankylosing spondylitis	0.000187	0.0452	CbGpPWpGaD
Lovastatin—Rash—Prednisolone—ankylosing spondylitis	0.000187	0.00179	CcSEcCtD
Lovastatin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000187	0.00179	CcSEcCtD
Lovastatin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000187	0.00179	CcSEcCtD
Lovastatin—Fatigue—Prednisone—ankylosing spondylitis	0.000186	0.00178	CcSEcCtD
Lovastatin—Headache—Prednisolone—ankylosing spondylitis	0.000186	0.00178	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—ankylosing spondylitis	0.000186	0.00178	CcSEcCtD
Lovastatin—Constipation—Prednisone—ankylosing spondylitis	0.000185	0.00177	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—ankylosing spondylitis	0.000182	0.00174	CcSEcCtD
Lovastatin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000181	0.00173	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00018	0.00173	CcSEcCtD
Lovastatin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00018	0.00173	CcSEcCtD
Lovastatin—Infection—Methotrexate—ankylosing spondylitis	0.000179	0.00172	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000178	0.0017	CcSEcCtD
Lovastatin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000178	0.0017	CcSEcCtD
Lovastatin—Asthenia—Betamethasone—ankylosing spondylitis	0.000178	0.0017	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000177	0.00169	CcSEcCtD
Lovastatin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000177	0.00169	CcSEcCtD
Lovastatin—Nausea—Prednisolone—ankylosing spondylitis	0.000176	0.00169	CcSEcCtD
Lovastatin—Pruritus—Betamethasone—ankylosing spondylitis	0.000175	0.00168	CcSEcCtD
Lovastatin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000175	0.00168	CcSEcCtD
Lovastatin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000174	0.00166	CcSEcCtD
Lovastatin—ITGAL—Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell—HLA-A—ankylosing spondylitis	0.000174	0.0419	CbGpPWpGaD
Lovastatin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000173	0.00166	CcSEcCtD
Lovastatin—Rash—Triamcinolone—ankylosing spondylitis	0.000172	0.00165	CcSEcCtD
Lovastatin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000172	0.00165	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—ankylosing spondylitis	0.000172	0.00165	CcSEcCtD
Lovastatin—Rash—Methylprednisolone—ankylosing spondylitis	0.000172	0.00165	CcSEcCtD
Lovastatin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000172	0.00164	CcSEcCtD
Lovastatin—Urticaria—Prednisone—ankylosing spondylitis	0.000172	0.00164	CcSEcCtD
Lovastatin—Headache—Triamcinolone—ankylosing spondylitis	0.000171	0.00164	CcSEcCtD
Lovastatin—Headache—Methylprednisolone—ankylosing spondylitis	0.000171	0.00163	CcSEcCtD
Lovastatin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000171	0.00163	CcSEcCtD
Lovastatin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000171	0.00163	CcSEcCtD
Lovastatin—ITGAL—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000171	0.0412	CbGpPWpGaD
Lovastatin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00017	0.00162	CcSEcCtD
Lovastatin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00017	0.00162	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000164	0.00157	CcSEcCtD
Lovastatin—Dizziness—Betamethasone—ankylosing spondylitis	0.000164	0.00157	CcSEcCtD
Lovastatin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000164	0.00157	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—ankylosing spondylitis	0.000163	0.00156	CcSEcCtD
Lovastatin—Nausea—Triamcinolone—ankylosing spondylitis	0.000162	0.00155	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000162	0.00155	CcSEcCtD
Lovastatin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000162	0.00155	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000161	0.00154	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000159	0.00152	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000159	0.00152	CcSEcCtD
Lovastatin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000158	0.00151	CcSEcCtD
Lovastatin—Vomiting—Betamethasone—ankylosing spondylitis	0.000158	0.00151	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000157	0.0015	CcSEcCtD
Lovastatin—Rash—Dexamethasone—ankylosing spondylitis	0.000156	0.0015	CcSEcCtD
Lovastatin—Rash—Betamethasone—ankylosing spondylitis	0.000156	0.0015	CcSEcCtD
Lovastatin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000156	0.00149	CcSEcCtD
Lovastatin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000156	0.00149	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—ankylosing spondylitis	0.000156	0.00149	CcSEcCtD
Lovastatin—Headache—Betamethasone—ankylosing spondylitis	0.000155	0.00149	CcSEcCtD
Lovastatin—Headache—Dexamethasone—ankylosing spondylitis	0.000155	0.00149	CcSEcCtD
Lovastatin—Asthenia—Prednisone—ankylosing spondylitis	0.000155	0.00148	CcSEcCtD
Lovastatin—Pain—Methotrexate—ankylosing spondylitis	0.000154	0.00148	CcSEcCtD
Lovastatin—Pruritus—Prednisone—ankylosing spondylitis	0.000153	0.00146	CcSEcCtD
Lovastatin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000149	0.00142	CcSEcCtD
Lovastatin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000148	0.00141	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000148	0.00141	CcSEcCtD
Lovastatin—Nausea—Betamethasone—ankylosing spondylitis	0.000147	0.00141	CcSEcCtD
Lovastatin—Nausea—Dexamethasone—ankylosing spondylitis	0.000147	0.00141	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—ankylosing spondylitis	0.000143	0.00137	CcSEcCtD
Lovastatin—Dizziness—Prednisone—ankylosing spondylitis	0.000143	0.00137	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000143	0.00137	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000143	0.00137	CcSEcCtD
Lovastatin—Vomiting—Prednisone—ankylosing spondylitis	0.000137	0.00131	CcSEcCtD
Lovastatin—Rash—Prednisone—ankylosing spondylitis	0.000136	0.0013	CcSEcCtD
Lovastatin—Dermatitis—Prednisone—ankylosing spondylitis	0.000136	0.0013	CcSEcCtD
Lovastatin—Headache—Prednisone—ankylosing spondylitis	0.000135	0.00129	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000133	0.00127	CcSEcCtD
Lovastatin—Asthenia—Methotrexate—ankylosing spondylitis	0.000129	0.00124	CcSEcCtD
Lovastatin—Nausea—Prednisone—ankylosing spondylitis	0.000128	0.00123	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—ankylosing spondylitis	0.000128	0.00122	CcSEcCtD
Lovastatin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000123	0.00118	CcSEcCtD
Lovastatin—Dizziness—Methotrexate—ankylosing spondylitis	0.000119	0.00114	CcSEcCtD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000118	0.0285	CbGpPWpGaD
Lovastatin—Vomiting—Methotrexate—ankylosing spondylitis	0.000115	0.0011	CcSEcCtD
Lovastatin—Rash—Methotrexate—ankylosing spondylitis	0.000114	0.00109	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000114	0.00109	CcSEcCtD
Lovastatin—Headache—Methotrexate—ankylosing spondylitis	0.000113	0.00108	CcSEcCtD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—RUNX3—ankylosing spondylitis	0.000109	0.0263	CbGpPWpGaD
Lovastatin—Nausea—Methotrexate—ankylosing spondylitis	0.000107	0.00103	CcSEcCtD
Lovastatin—ITGAL—Immune System—KIR3DL1—ankylosing spondylitis	0.000103	0.025	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—ERAP1—ankylosing spondylitis	9.8e-05	0.0237	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	8.16e-05	0.0197	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—MMP3—ankylosing spondylitis	7.24e-05	0.0175	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1R2—ankylosing spondylitis	6.27e-05	0.0151	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—ERAP1—ankylosing spondylitis	5.94e-05	0.0143	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HLA-C—ankylosing spondylitis	5.63e-05	0.0136	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CARD9—ankylosing spondylitis	5.44e-05	0.0131	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL10—ankylosing spondylitis	5.39e-05	0.013	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD79A—ankylosing spondylitis	4.29e-05	0.0104	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	3.96e-05	0.00957	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	3.61e-05	0.00871	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—CD40LG—ankylosing spondylitis	3.5e-05	0.00845	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HLA-C—ankylosing spondylitis	3.41e-05	0.00824	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	3.39e-05	0.00818	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HLA-B—ankylosing spondylitis	3.33e-05	0.00803	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	3.29e-05	0.00794	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.08e-05	0.00744	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1RN—ankylosing spondylitis	2.97e-05	0.00716	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	2.86e-05	0.0069	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	2.61e-05	0.00631	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD79A—ankylosing spondylitis	2.6e-05	0.00629	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	2.43e-05	0.00587	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—ankylosing spondylitis	2.3e-05	0.00556	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	2.27e-05	0.00548	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ANTXR2—ankylosing spondylitis	2.23e-05	0.00537	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL1A—ankylosing spondylitis	2.13e-05	0.00515	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CD40LG—ankylosing spondylitis	2.12e-05	0.00512	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HLA-B—ankylosing spondylitis	2.02e-05	0.00487	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HLA-A—ankylosing spondylitis	1.87e-05	0.00452	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	1.79e-05	0.00431	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CRP—ankylosing spondylitis	1.78e-05	0.00431	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	1.78e-05	0.00429	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	1.78e-05	0.00429	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—TLR4—ankylosing spondylitis	1.71e-05	0.00413	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.7e-05	0.0041	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	1.69e-05	0.00408	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	1.57e-05	0.00378	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—B3GNT2—ankylosing spondylitis	1.37e-05	0.00332	CbGpPWpGaD
Lovastatin—HDAC2—Disease—B3GNT2—ankylosing spondylitis	1.31e-05	0.00317	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—B3GNT2—ankylosing spondylitis	1.12e-05	0.0027	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—B3GNT2—ankylosing spondylitis	9.52e-06	0.0023	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—B3GNT2—ankylosing spondylitis	8.29e-06	0.002	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—B3GNT2—ankylosing spondylitis	7.74e-06	0.00187	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—B3GNT2—ankylosing spondylitis	7.09e-06	0.00171	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	6.76e-06	0.00163	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	6.51e-06	0.00157	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTGER4—ankylosing spondylitis	6.3e-06	0.00152	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HLA-A—ankylosing spondylitis	5.31e-06	0.00128	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	4.71e-06	0.00114	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP3—ankylosing spondylitis	4.49e-06	0.00108	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	4.08e-06	0.000984	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	3.64e-06	0.000878	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	3.55e-06	0.000857	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—B3GNT2—ankylosing spondylitis	3.35e-06	0.000808	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.34e-06	0.000805	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	3.32e-06	0.000801	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	2.19e-06	0.000528	CbGpPWpGaD
